TCG Crossover Management, LLC
Filing Date
Global Rank
#669
/ 8,232
▲ 159
Top Industry
Biotechnology
93.1%
3Y Alpha vs SPY
+19.8%
Period ended 2 months ago
Filed May 15, 2026 · 30d
18 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+178.2%
SPY
+76.3%
Annualised alpha
+19.8%
Max drawdown
−57.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
49 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
20.6%
−12.1 pts
Top 5
44.3%
−8.2 pts
Top 10
60.9%
−4.9 pts
HHI
688
Diversified−578
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $3,501,388,578 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | +2,797,055 | 4,457,988 | $110,736,421 | |
| RLAY | Relay Therapeutics, Inc. | +1,053,170 | 4,273,356 | $42,519,892 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +1,000,000 | 1,062,049 | $98,112,086 | |
| TYRA | Tyra Biosciences, Inc. | +350,877 | 3,248,980 | $124,435,934 | |
| AVTX | Avalo Therapeutics, Inc. | +255,383 | 738,383 | $11,024,058 | |
| TRDA | Entrada Therapeutics, Inc. | +199,108 | 2,287,500 | $28,868,250 | |
| RVMD | Revolution Medicines, Inc. | +140,000 | 576,473 | $56,061,999 | |
| LBRX | Lb Pharmaceuticals Inc | +94,474 | 1,839,489 | $45,361,798 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc | −4,092,479 | 1,647,752 | $13,956,459 | |
| TNGX | Tango Therapeutics, Inc. | −2,231,023 | 10,531,071 | $220,310,005 | |
| LQDA | Liquidia Corp | −1,307,036 | 403,048 | $15,211,031 | |
| COGT | Cogent Biosciences, Inc. | −921,268 | 4,946,894 | $190,405,950 | |
| GPCR | Structure Therapeutics Inc. | −780,446 | 140,411 | $6,767,810 | |
| ABVX | Abivax S.A. | −630,511 | 6,481,085 | $721,668,814 | |
| UPB | Upstream Bio, Inc. | −562,823 | 181,063 | $1,629,567 | |
| URGN | UroGen Pharma Ltd. | −311,982 | 405,365 | $7,288,462 | |
| ARVN | Arvinas, Inc. | −278,755 | 2,387,461 | $25,307,086 | |
| MNPR | Monopar Therapeutics | −9,812 | 132,103 | $7,237,923 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | 11,020,968 | $104,919,615 | |
| VOR | Vor Biopharma Inc. | 5,673,078 | $101,207,711 | |
| IRON | Disc Medicine, Inc. | 1,341,862 | $85,798,656 | |
| SRZN | Surrozen, Inc./DE | 1,473,101 | $42,911,432 | |
| IPSC | Century Therapeutics, Inc. | 17,754,430 | $40,125,011 | |
| TECX | Tectonic Therapeutic, Inc. | 1,204,891 | $37,243,180 | |
| CATX | Perspective Therapeutics, Inc. | 7,915,567 | $33,007,914 | |
| ALXO | Alx Oncology Holdings Inc | 13,011,849 | $26,088,757 | |
| AGMB | Agomab Therapeutics NV | 2,053,233 | $21,538,414 | |
| CNTX | Context Therapeutics Inc. | 2,682,696 | $7,028,663 | |
| CGEM | Cullinan Therapeutics, Inc. | 406,786 | $5,780,429 | |
| No positions match the current search. | ||||
49 positions ·
$3,501,388,578 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 6,481,085 | $721,668,814 | 20.61% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Held | 3,670,206 | $248,399,542 | 7.09% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 10,531,071 | $220,310,005 | 6.29% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 4,946,894 | $190,405,950 | 5.44% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Held | 4,286,480 | $170,258,985 | 4.86% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 1,676,624 | $140,702,286 | 4.02% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 3,248,980 | $124,435,934 | 3.55% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 4,457,988 | $110,736,421 | 3.16% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
NEW | 11,020,968 | $104,919,615 | 3.00% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
NEW | 5,673,078 | $101,207,711 | 2.89% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 1,062,049 | $98,112,086 | 2.80% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 1,900,582 | $95,865,356 | 2.74% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Held | 6,243,812 | $86,788,986 | 2.48% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 1,341,862 | $85,798,656 | 2.45% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Held | 4,615,144 | $83,672,560 | 2.39% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Held | 4,622,151 | $76,034,383 | 2.17% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 12,362,205 | $67,497,639 | 1.93% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 576,473 | $56,061,999 | 1.60% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Held | 1,445,538 | $55,103,908 | 1.57% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Added | 1,839,489 | $45,361,798 | 1.30% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
NEW | 1,473,101 | $42,911,432 | 1.23% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Held | 11,390,175 | $42,713,156 | 1.22% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 4,273,356 | $42,519,892 | 1.21% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Held | 5,250,000 | $40,267,500 | 1.15% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 17,754,430 | $40,125,011 | 1.15% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 4,631,317 | $39,180,941 | 1.12% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
NEW | 1,204,891 | $37,243,180 | 1.06% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
NEW | 7,915,567 | $33,007,914 | 0.94% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 2,452,138 | $29,572,784 | 0.84% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
Added | 2,287,500 | $28,868,250 | 0.82% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
NEW | 13,011,849 | $26,088,757 | 0.75% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Reduced | 2,387,461 | $25,307,086 | 0.72% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 1,789,617 | $24,875,676 | 0.71% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 2,053,233 | $21,538,414 | 0.62% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 10,000,000 | $21,500,000 | 0.61% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 650,000 | $19,402,500 | 0.55% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 3,033,560 | $15,986,861 | 0.46% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 403,048 | $15,211,031 | 0.43% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 1,647,752 | $13,956,459 | 0.40% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 738,383 | $11,024,058 | 0.31% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Reduced | 405,365 | $7,288,462 | 0.21% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Reduced | 132,103 | $7,237,923 | 0.21% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
NEW | 2,682,696 | $7,028,663 | 0.20% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 140,411 | $6,767,810 | 0.19% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
NEW | 406,786 | $5,780,429 | 0.17% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 464,398 | $4,774,011 | 0.14% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Held | 416,301 | $4,712,527 | 0.13% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Reduced | 181,063 | $1,629,567 | 0.05% | |
| VTGN |
Vistagen Therapeutics, Inc.
Healthcare
|
Held | 2,676,580 | $1,525,650 | 0.04% |